Katz Richard D 4
4 · ARGOS THERAPEUTICS INC · Filed Aug 31, 2017
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Common Stock
2017-08-30+395,664→ 399,622 total
Footnotes (1)
- [F1]The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 197,832 shares on January 2, 2018, and with respect to the remaining 197,832 shares on January 9, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.